← Open Payments lookup

MEEGHAN ESCOBAR: Open Payments

NPI 1548025364 · TUCSON, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$913 in 53 payments from 18 companies in 2025. Trend: 2023 $0 · 2024 $135 · 2025 $913

Food & beverage: $913
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP7$117
Lilly USA, LLC6$103
GlaxoSmithKline, LLC.6$97
ABBVIE INC.4$77
Merck Sharp & Dohme LLC3$61
Amgen Inc.4$59
Novo Nordisk Inc3$50
PFIZER INC.3$46
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$39
Abbott Laboratories2$36

Products named: AIRSUPRA, MOUNJARO, SHINGRIX, GARDASIL 9, JARDIANCE, UBRELVY, CAPLYTA, FREESTYLE LIBRE 3.

Industry payments across AZ — which companies pay providers there.